Polaris Group (TPE:6550) ROE % Adjusted to Book Value : -10.06% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Polaris Group ROE % Adjusted to Book Value?

Polaris Group's ROE % for the quarter that ended in Dec. 2024 was -52.84%. Polaris Group's PB Ratio for the quarter that ended in Dec. 2024 was 5.25. Polaris Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -10.06%.

Polaris Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Polaris Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris Group ROE % Adjusted to Book Value Chart

Polaris Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.51

-2.02

-1.91

-2.45

-6.76

Polaris Group Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-3.43	-2.90	-3.87	-6.55	-10.06

Competitive Comparison of Polaris Group's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Polaris Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polaris Group's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Polaris Group's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Polaris Group ROE % Adjusted to Book Value Calculation

Polaris Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-35.50%	/	5.25
	=	-6.76%

Polaris Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-52.84%	/	5.25
	=	-10.06%

Polaris Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Polaris Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Polaris Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN

Website

https://www.polarispharma.com

Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines